Management of rapidly progressive precocious puberty in a patient with mosaic turner syndrome

dc.contributor.author	Özcabi, B.
dc.contributor.author	Kirmizibekmez, H.
dc.contributor.author	Yesiltepe, Mutlu, G.
dc.contributor.author	Dursun, F.
dc.contributor.author	Guran, T.
dc.date.accessioned	2021-12-21T08:40:35Z
dc.date.available	2021-12-21T08:40:35Z
dc.date.issued	2021
dc.identifier.issn	18410987
dc.identifier.uri	https://doi.org/10.4183/aeb.2021.101
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1085
dc.description.abstract	Context. Rapidly progressive precocious puberty (RPPP) is a rare condition in Turner syndrome (TS), with no consensus on treatment and follow-up. Only 12 cases have been reported so far. Objective. We aimed to evaluate the effects of the GnRH analog (GnRH
dc.language.iso	English
dc.publisher	Acta Endocrinologica Foundation
dc.rights	All Open Access, Green
dc.title	Management of rapidly progressive precocious puberty in a patient with mosaic turner syndrome
dc.type	Article
dc.relation.journal	Acta Endocrinologica
dc.identifier.issue	1
dc.identifier.startpage	101
dc.identifier.endpage	105
dc.identifier.volume	17
dc.identifier.doi	10.4183/aeb.2021.101
dc.relation.issue	1
dc.relation.volume	17

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.